4DMT | Powering The Future Of Genetic Medicines

4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions.

Corinne Clawson

Director, People Advisor at 4DMT | Powering The Future Of Genetic Medicines

Joseph Vacca

Scientist 1 at 4DMT | Powering The Future Of Genetic Medicines

Melissa Cowan

HR Systems and Operations Manager at 4DMT | Powering The Future Of Genetic Medicines

Gloria Nam

Corporate Controller at 4DMT | Powering The Future Of Genetic Medicines

Angela Arafelis

Administrative Assistant at 4DMT | Powering The Future Of Genetic Medicines

August Moretti

Board Member at 4DMT | Powering The Future Of Genetic Medicines

Julian Pei

Director, Corporate Finance and FP and A at 4DMT | Powering The Future Of Genetic Medicines

Peter Francis

Chief Scientific Officer, Chief Medical Officer at 4DMT | Powering The Future Of Genetic Medicines

Catherine Campbell

Vice President, Regulatory Affairs, Quality and GxP Compliance at 4DMT | Powering The Future Of Genetic Medicines

Sara Lin

4DMT | Powering The Future Of Genetic Medicines

Theresa Janke

Chief Of Staff at 4DMT | Powering The Future Of Genetic Medicines